INSP (Inspire Medical Systems) Financial Strength: 10 (As of Jun. 2026) — 25% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INSP Inspire Medical Systems Inc INSP
58 GF Score
Price $73.00
GF Value $190.21
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Inspire Medical Systems Financial Strength?

Inspire Medical Systems INSP +7.16% 58 Financial Strength is 10 as of Jun. 2026, which is 25% above its 10-year median of 8.00. GuruFocus rates INSP with a GF Score™ of 58/100 and a GF Value™ of $190.21 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Inspire Medical Systems has the Financial Strength Rank of 10. It shows strong financial strength and is unlikely to fall into distressed situations.

Good Sign:

Inspire Medical Systems Inc shows strong financial strength.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

GuruFocus does not calculate Inspire Medical Systems's interest coverage with the available data. Inspire Medical Systems's debt to revenue ratio for the quarter that ended in Jun. 2026 was 0.04. As of today, Inspire Medical Systems's Altman Z-Score is 13.44.


Inspire Medical Systems  (NYSE:INSP) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Inspire Medical Systems has the Financial Strength Rank of 10. It shows strong financial strength and is unlikely to fall into distressed situations.


Inspire Medical Systems Financial Strength Related Terms


INSP vs CNMD, TNDM, NVCR: Financial Strength Comparison

For the Medical Devices subindustry, Inspire Medical Systems's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspire Medical Systems Financial Strength vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's Financial Strength distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's Financial Strength falls into.


INSP
58GF Score
Inspire Medical Systems Inc INSP
Financial Strength is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspire Medical Systems Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Inspire Medical Systems's Interest Expense for the months ended in Jun. 2026 was $0.0 Mil. Its Operating Income for the months ended in Jun. 2026 was $-0.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $29.1 Mil.

Inspire Medical Systems's Interest Coverage for the quarter that ended in Jun. 2026 is

GuruFocus does not calculate Inspire Medical Systems's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Inspire Medical Systems Inc has enough cash to cover all of its debt. Its financial situation is stable.

2. Debt to revenue ratio. The lower, the better.

Inspire Medical Systems's Debt to Revenue Ratio for the quarter that ended in Jun. 2026 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2026 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 29.093) / 802.324
=0.04

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Inspire Medical Systems has a Z-score of 13.44, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 13.44 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Financial Strength →
What does a Financial Strength of 10 mean?
Inspire Medical Systems (INSP) has a Financial Strength of 10 as of Jun. 2026. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on Inspire Medical Systems and its competitors. This is 25% above median its historical median of 8.00. Over the past decade, Inspire Medical Systems' Financial Strength has ranged from 3.00 to 10.00.
Is Inspire Medical Systems' Financial Strength too high?
Inspire Medical Systems' current Financial Strength of 10 is 25% above median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, Inspire Medical Systems has a GF Score™ of 58/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' Financial Strength compare to CNMD and TNDM?
Inspire Medical Systems' Financial Strength of 10 can be compared against companies in the Medical Devices & Instruments industry. Historically, Inspire Medical Systems' own Financial Strength has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Financial Strength for a Medical Devices & Instruments company?
A good Financial Strength depends on the Medical Devices & Instruments industry context. However, Financial Strength should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Financial Strength mean?
A high Financial Strength can signal that a stock is expensive relative to its fundamentals. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on Inspire Medical Systems and its competitors. Inspire Medical Systems's current Financial Strength is 10, which is 25% above median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (INSP) is currently considered Significantly Undervalued. The stock's GF Value™ is $190.21, compared to a current price of $73.00 — trading 61.6% below its estimated fair value. The current Financial Strength is 10, which is 25% above median its 10-year median of 8.00. Inspire Medical Systems' overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Financial Strength calculated?
Financial Strength is calculated from a company's financial statements. For Inspire Medical Systems (INSP), the current Financial Strength is 10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspire Medical Systems (INSP) Overvalued in 2026?

Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued. The current stock price of $73.00 is trading 61.6% below its estimated GF Value™ of $190.21. GuruFocus considers Inspire Medical Systems to be Significantly Undervalued.

Key valuation signals for INSP:

  • Financial Strength: 10 (25% above median its 10-year median of 8.00)
  • GF Value™: $190.21 vs. price of $73.00 (61.6% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the INSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Inspire Medical Systems Business Description

Other Exchanges 2DR:Germany
Address 5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
58GF Score

Get the complete analysis for INSP

Financial Strength is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$73.00
Price
$190.21
GF Value